TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.
Nanosonics Limited’s Sustainability Report for FY25 highlights the company’s significant impact on infection prevention, having protected over 28 million patients from cross-contamination risks. The report outlines Nanosonics’ commitment to sustainability, detailing its performance and future targets, which are crucial for its operations and stakeholder engagement.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.15 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the infection prevention industry, focusing on developing and distributing innovative disinfection products. The company’s primary product, the trophon® unit, is widely used to prevent cross-contamination in healthcare settings, with a global installed base of 37,000 units.
YTD Price Performance: 34.55%
Average Trading Volume: 725,502
Technical Sentiment Signal: Buy
Current Market Cap: A$1.23B
Learn more about NAN stock on TipRanks’ Stock Analysis page.